MENU
+Compare
IQV
Stock ticker: NYSE
AS OF
Dec 18, 12:14 PM (EDT)
Price
$196.75
Change
+$0.11 (+0.06%)
Capitalization
45.3B

IQV IQVIA Holdings Forecast, Technical & Fundamental Analysis

a provider of biopharmaceutical development services and commercial outsourcing services

IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for IQV with price predictions
Dec 17, 2024

IQV's Indicator enters downward trend

The Aroon Indicator for IQV entered a downward trend on November 27, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 204 similar instances where the Aroon Indicator formed such a pattern. In of the 204 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on IQV as a result. In of 68 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IQV's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for IQV just turned positive on November 25, 2024. Looking at past instances where IQV's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IQV advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

IQV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IQV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.413) is normal, around the industry mean (23.300). P/E Ratio (34.139) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (1.417) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.094) is also within normal values, averaging (43.338).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IQV is expected to report earnings to rise 9.51% to $3.11 per share on February 12

IQVIA Holdings IQV Stock Earnings Reports
Q4'24
Est.
$3.11
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.07
Q1'24
Beat
by $0.06
Q4'23
Beat
by $0.02
The last earnings report on October 31 showed earnings per share of $2.84, beating the estimate of $2.81. With 50.98K shares outstanding, the current market capitalization sits at 45.30B.
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical development services and commercial outsourcing services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2400 Ellis Road
Phone
+1 919 998-2000
Employees
87000
Web
https://www.iqvia.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGNE179.062.73
+1.55%
BeiGene Ltd
PT0.930.01
+1.09%
Pintec Technology Holdings Limited
SRAD17.460.01
+0.06%
Sportradar Group AG
HPP3.13-0.05
-1.57%
Hudson Pacific Properties
XBIT6.74-0.18
-2.60%
XBiotech

IQV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
-0.23%
CRL - IQV
73%
Closely correlated
-0.39%
ICLR - IQV
65%
Loosely correlated
-0.45%
TMO - IQV
57%
Loosely correlated
-0.27%
BRKR - IQV
56%
Loosely correlated
+1.10%
MEDP - IQV
55%
Loosely correlated
-0.36%
More

Groups containing IQV

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
-0.23%
IQV
(2 stocks)
92%
Closely correlated
+0.01%